GO:1904358 positive regulation of telomere maintenance via telomere lengthening: Telomere Elongation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904358 describes any process that activates or increases the frequency, rate or extent of telomere maintenance via telomere lengthening.
• The term sits within the biological_process ontology and is a positive regulatory node upstream of telomere elongation mechanisms.
• Two major molecular routes support telomere lengthening: telomerase-mediated extension and the alternative lengthening of telomeres (ALT) pathway [2,4].
• TERT, POLD3, NPM1, HDAC9 and TERRA-associated factors are among the proteins experimentally linked to telomere maintenance via lengthening [2,6,7,8].
• ALT-positive cancers and TERT-driven tumors are the most studied disease contexts for this GO term [2,4,7].
• CRISPR knockout, point-mutation, knock-in and overexpression models are standard tools for dissecting positive regulators of telomere lengthening [2,6,8].
Description
GO:1904358, positive regulation of telomere maintenance via telomere lengthening, is a Gene Ontology biological_process term that captures any process which activates or increases the frequency, rate or extent of telomere maintenance via telomere lengthening. Telomeres are nucleoprotein structures that protect chromosome ends, and their maintenance by lengthening is essential for replicative immortality in stem cells and in most cancers [2,7]. Because the term is a positive regulatory node, it is used to annotate gene products that stimulate, rather than merely permit, telomere elongation. Researchers encounter GO:1904358 when studying telomerase-dependent extension, alternative lengthening of telomeres (ALT), and the signaling or chromatin events that license these pathways [2,4]. The term is deliberately distinct from the core elongation reactions themselves; it captures upstream activators, stabilizers, and pathway-amplifying factors [2,6]. This distinction matters because positive regulators are often the most tractable therapeutic targets and the most informative CRISPR screening hits [2,6]. In practice, GO:1904358 is used in functional genomics to group genes whose perturbation changes telomere length in a lengthening direction [2,6,8]. It is therefore a useful anchor for interpreting RNA-seq, proteomics, and imaging experiments in ALT-positive osteosarcoma, pancreatic neuroendocrine tumors, and other telomere-driven malignancies [2,4,5].
positive regulation of telomere maintenance via telomere lengthening At A Glance
| GO ID | GO:1904358 |
|---|---|
| GO term | positive regulation of telomere maintenance via telomere lengthening |
| Ontology | biological_process |
| Synonym | activation of telomere maintenance via telomere lengthening; up regulation of telomere maintenance via telomere lengthening; up-regulation of telomere maintenance via telomere lengthening; upregulation of telomere maintenance via telomere lengthening |
| Major function | Positive regulation of telomere maintenance by increasing telomere lengthening |
| Biological context | Telomerase-dependent and ALT-dependent telomere elongation pathways [2,4] |
| Representative regulators | TERT, POLD3, NPM1, HDAC9, TERRA-associated factors [2,6,7,8] |
| Disease relevance | ALT-positive osteosarcoma, TERT-linked cancers, pancreatic neuroendocrine tumors [2,4,5,7] |
| Research methods | CRISPR KO, point mutation, knock-in, overexpression, RNA-seq, proteomics, imaging [2,6,8] |
What Is GO:1904358?
In plain terms, GO:1904358 is the GO label for any biological activity that boosts telomere maintenance by making telomeres longer. The QuickGO definition states: any process that activates or increases the frequency, rate or extent of telomere maintenance via telomere lengthening. It is a positive regulation term, so it is applied to gene products that stimulate telomere elongation rather than to the elongation machinery itself.
Why Is positive regulation of telomere maintenance via telomere lengthening Important in Cell Biology?
GO:1904358 matters because positive regulators of telomere lengthening determine whether a cell can sustain telomeres and escape replicative senescence, a hallmark of cancer and a key property of stem cells [2,7]. In ALT-positive osteosarcoma, NPM1 phosphorylation stabilizes POLD3 and drives telomere maintenance via lengthening, illustrating how a single positive regulator can be therapeutically actionable. In TERT-driven tumors, TERT links telomere length to genomic instability and immune modulation, making the positive regulation node a systems-level hub. Because the term groups upstream activators rather than the core elongation machinery, it is especially useful for prioritizing CRISPR screening hits and drug targets [2,6].
• Defines the positive regulatory layer that licenses telomere elongation in stem cells and cancer cells [2,7].
• Provides a GO annotation target for ALT pathway activators such as NPM1 and POLD3.
• Links telomere lengthening to genomic instability and immune modulation through TERT.
• Supports interpretation of CRISPR screens that identify telomere length regulators [2,6].
• Connects chromatin and histone-modifying enzymes such as HDAC9 to ALT-associated PML bodies.
• Relevant to ALT tumor diagnosis and treatment, including Trabectedin-based strategies.
• Provides a framework for studying TERRA transcription and telomere replication in yeast models.
• Helps distinguish positive regulators from core elongation factors in functional genomics.
• Informs experimental models of pancreatic neuroendocrine tumors with recurrent fusion genes.
• Guides therapeutic hypothesis generation in telomere-driven malignancies [2,4,7].
What Happens During positive regulation of telomere maintenance via telomere lengthening?
Activation of telomerase-dependent lengthening
In simple terms: The cell switches on the enzyme that adds DNA repeats to chromosome ends.
Positive regulation of telomere maintenance via telomere lengthening includes processes that increase telomerase-dependent extension of telomeric DNA [2,7]. TERT is the catalytic subunit whose expression and activity are central to this route, and its regulation links telomere length to genomic instability and immune modulation. In this stage, upstream activators raise the frequency or rate of telomerase action at chromosome ends, which is the defining outcome of GO:1904358.
Activation of the alternative lengthening of telomeres (ALT) pathway
In simple terms: Some cells lengthen telomeres without telomerase, using a recombination-like backup route.
The ALT pathway is a telomerase-independent route for telomere lengthening, and positive regulators of this route fall under GO:1904358 [2,4]. NPM1 phosphorylation stabilizes POLD3 and promotes telomere maintenance via lengthening in ALT-positive osteosarcoma, providing a mechanistic example of positive regulation. HDAC9 regulates the ALT pathway through formation of ALT-associated PML bodies, showing that chromatin-modifying enzymes can act as positive regulators. ALT tumors are a clinically distinct group for which Trabectedin has been proposed as a therapeutic option.
Stabilization of elongation factors
In simple terms: Helper proteins keep the lengthening machinery stable so it can keep working.
Positive regulation often works by stabilizing components of the elongation machinery rather than by directly catalyzing DNA synthesis. NPM1 phosphorylation-mediated stabilization of POLD3 is a concrete example in which a regulatory modification increases the availability of a DNA synthesis factor at telomeres. This stabilization step increases the extent of telomere lengthening and is therefore annotated to GO:1904358.
Chromatin and transcription-linked regulation
In simple terms: How DNA is packaged and transcribed can turn telomere lengthening up or down.
Chromatin state and telomeric transcription influence positive regulation of telomere lengthening [6,8]. HDAC9 acts through ALT-associated PML bodies, linking histone deacetylation to ALT pathway activity. In Saccharomyces cerevisiae, the Ess1 prolyl isomerase represses TERRA transcription and promotes telomere replication, showing that transcription-linked factors can positively regulate telomere maintenance. These examples illustrate that GO:1904358 encompasses chromatin and RNA-level activators, not only canonical telomerase components [6,8].
Integration with genome stability networks
In simple terms: Telomere lengthening is wired into the cell's broader DNA stability system.
Positive regulation of telomere maintenance via telomere lengthening intersects with genome stability pathways [3,7]. VID22 counteracts G-quadruplex-induced genome instability, connecting telomere-associated structures to genome maintenance. TERT links telomere length to cancer risk by integrating genomic instability and immune modulation, showing that positive regulation of lengthening has systems-level consequences. These interactions place GO:1904358 within a broader network that determines whether telomere elongation is beneficial or deleterious [3,7].
Key Genes Involved in GO:1904358 positive regulation of telomere maintenance via telomere lengthening
The following genes and proteins have been experimentally linked to positive regulation of telomere maintenance via telomere lengthening or to closely related telomere elongation mechanisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TERT | Catalytic subunit of telomerase; supports telomere lengthening | Links telomere length to cancer risk, genomic instability and immune modulation |
| POLD3 | DNA synthesis factor stabilized during ALT-mediated telomere maintenance | Target of NPM1 phosphorylation in ALT-positive osteosarcoma |
| NPM1 | Phosphorylation-mediated stabilizer of POLD3 in ALT | Positive regulator of telomere maintenance via lengthening in osteosarcoma |
| HDAC9 | Histone deacetylase regulating ALT-associated PML bodies | Chromatin-level positive regulator of the ALT pathway |
| TERRA-associated factors | Telomeric repeat-containing RNA regulation | Linked to telomere replication and transcription control |
| Ess1 | Prolyl isomerase repressing TERRA transcription in yeast | Model for transcription-linked positive regulation of telomere replication |
| VID22 | Counteracts G-quadruplex-induced genome instability | Connects telomere structures to genome stability |
| BEND2 | Recurrent fusion gene in pancreatic neuroendocrine tumors | Candidate context for telomere-related tumor biology |
| Muscle satellite cell factors | Satellite cell dysfunction in neuromuscular disorders | Broader context for telomere-related cell maintenance |
| ALT pathway components | Telomerase-independent telomere lengthening | Therapeutic target space in ALT tumors |
| PML body proteins | ALT-associated PML body formation | Structural platform for ALT regulation |
| Telomerase holoenzyme components | Telomerase-dependent lengthening | Core machinery positively regulated under GO:1904358 |
| DNA recombination factors | ALT-mediated recombination [2,4] | Mechanistic contributors to telomere lengthening [2,4] |
| Chromatin modifiers | Histone acetylation/deacetylation at telomeres | Upstream regulators of ALT activity |
| Genome stability factors | G-quadruplex resolution and DNA repair | Modifiers of telomere maintenance outcomes |
How Is positive regulation of telomere maintenance via telomere lengthening Regulated?
Positive regulation of telomere maintenance via telomere lengthening is controlled at multiple levels, including post-translational modification, chromatin state, and transcription [2,6,8]. NPM1 phosphorylation stabilizes POLD3 and increases ALT-mediated telomere lengthening, illustrating a phosphorylation-dependent regulatory input. HDAC9 regulates the ALT pathway via ALT-associated PML bodies, showing that histone deacetylation is a regulatory layer. In yeast, the Ess1 prolyl isomerase represses TERRA transcription and promotes telomere replication, demonstrating transcription-linked control. TERT integrates telomere length with genomic instability and immune modulation, indicating that positive regulation is embedded in broader cellular signaling.
positive regulation of telomere maintenance via telomere lengthening and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NPM1 / POLD3 | ALT-positive osteosarcoma | ALT-positive osteosarcoma cell lines with NPM1 or POLD3 knockout |
| TERT | TERT-linked cancers and genomic instability | TERT overexpression and point-mutation models in cancer cell lines |
| HDAC9 | ALT pathway and ALT-associated PML bodies | HDAC9 knockout or overexpression in ALT cell models |
| BEND2 | Pancreatic neuroendocrine tumors | Fusion knock-in models in pancreatic neuroendocrine cells |
| VID22 | G-quadruplex-induced genome instability | Yeast VID22 deletion and genome stability assays |
ALT-positive osteosarcoma
ALT-positive osteosarcoma relies on telomerase-independent telomere lengthening, and NPM1 phosphorylation-mediated stabilization of POLD3 promotes telomere maintenance via lengthening in this disease. This makes positive regulators of GO:1904358 attractive therapeutic targets in ALT-positive tumors. ALT tumors more broadly are a distinct diagnostic group for which Trabectedin has been proposed as a treatment option.
TERT-linked cancers
TERT links telomere length to cancer risk by integrating genomic instability and immune modulation, placing positive regulation of telomere lengthening at the center of TERT-driven tumor biology. Because TERT activity determines whether telomeres are maintained, regulators annotated to GO:1904358 can influence cancer initiation and progression.
Pancreatic neuroendocrine tumors
Recurrent BEND2 fusion genes identified by whole transcriptome sequencing in nonfunctional pancreatic neuroendocrine tumors correlate with poor patient prognosis, providing a tumor context in which telomere-related pathways may be relevant. This highlights the need to test whether such fusions intersect with positive regulation of telomere maintenance via telomere lengthening.
Genome instability syndromes and neuromuscular disorders
VID22 counteracts G-quadruplex-induced genome instability, linking telomere-associated structures to genome maintenance and disease-relevant instability. In addition, muscle satellite cell dysfunction is implicated in neuromuscular disorders, providing a broader context in which telomere maintenance and cell regenerative capacity intersect.
From positive regulation of telomere maintenance via telomere lengthening-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for telomere lengthening? | CRISPR knockout in ALT-positive or telomerase-positive cell lines [2,6] |
| Does a specific phosphorylation site regulate telomere maintenance? | Point-mutation knock-in of phospho-dead or phospho-mimetic residues |
| Does a fusion gene drive telomere-related tumor biology? | Knock-in of the fusion allele in relevant cell models |
| Does overexpression of a regulator increase telomere length? | Overexpression cell models with telomere length measurement |
| Which chromatin factors regulate ALT activity? | HDAC9 knockout and ALT-associated PML body imaging |
| How does transcription affect telomere replication? | Yeast Ess1 mutants with TERRA transcription assays |
How to Study the positive regulation of telomere maintenance via telomere lengthening Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Telomere length assay | Average or distribution of telomere lengths [2,7] | Testing whether a regulator increases lengthening |
| RNA-seq | Transcriptome including TERRA and telomere-related genes | Identifying transcription-linked regulators |
| Phosphoproteomics | Phosphorylation-dependent stabilization events | Detecting NPM1-POLD3 regulatory events |
| Immunofluorescence imaging | ALT-associated PML bodies and telomere foci | Assessing ALT pathway activity |
| CRISPR knockout screening | Gene requirements for telomere maintenance [2,6] | Prioritizing positive regulators |
| Overexpression assays | Gain-of-function effects on telomere length | Testing TERT and other activators |
| Yeast genetics | TERRA transcription and telomere replication | Modeling transcription-linked regulation |
| Genome stability assays | G-quadruplex-induced instability | Linking telomere structures to genome maintenance |
Telomere length measurement
Telomere length assays are the primary readout for positive regulation of telomere maintenance via telomere lengthening [2,7]. These assays quantify terminal restriction fragments or telomere fluorescence signals to determine whether a perturbation increases lengthening. In ALT-positive osteosarcoma, telomere length measurement is used together with POLD3 stabilization assays to test NPM1-dependent regulation.
RNA-seq and transcriptomics
RNA-seq can identify transcriptional changes in telomere-related genes and TERRA after perturbation of candidate regulators. In yeast, TERRA transcription is measured to determine how factors such as Ess1 affect telomere replication. Transcriptomic profiling also supports interpretation of fusion-driven tumors such as BEND2-fusion pancreatic neuroendocrine tumors.
Proteomics and post-translational modification analysis
Proteomics and phosphoproteomics are used to detect stabilization events such as NPM1 phosphorylation-mediated POLD3 stabilization. These methods reveal whether a positive regulator acts by modifying the abundance or modification state of elongation factors. They are complementary to genetic perturbation and help establish causality.
Imaging of telomere-associated structures
Imaging of ALT-associated PML bodies and telomere foci is used to assess pathway activity and chromatin-level regulation. HDAC9 regulation of the ALT pathway was studied through ALT-associated PML body formation, demonstrating the value of imaging readouts. Imaging can also reveal genome instability phenotypes linked to G-quadruplex resolution.
How CRISPR Can Be Used to Study GO:1904358 positive regulation of telomere maintenance via telomere lengthening
Knockout
CRISPR knockout is used to test whether a candidate gene is required for positive regulation of telomere maintenance via telomere lengthening [2,6]. For example, knocking out HDAC9 or NPM1-pathway components can reveal loss of ALT activity or telomere lengthening defects [2,6]. Knockout models are typically paired with telomere length measurement and imaging readouts [2,6].
Point Mutation
Point-mutation knock-in is used to dissect specific residues, such as phosphorylation sites that control stabilization of elongation factors. Phospho-dead or phospho-mimetic mutations of NPM1 can test whether phosphorylation is required for POLD3 stabilization and telomere maintenance. This approach provides causal evidence beyond simple loss-of-function.
Knock-in
Knock-in models are used to introduce fusion alleles or tagged alleles that report on telomere-related pathways. Recurrent BEND2 fusion genes in pancreatic neuroendocrine tumors can be modeled by knock-in to test their contribution to tumor biology. Tagged knock-in of telomere regulators enables imaging and proteomic tracking.
Overexpression
Overexpression models test whether increasing the dose of a regulator is sufficient to enhance telomere lengthening. TERT overexpression is a classic gain-of-function approach for studying telomere maintenance and cancer risk. Overexpression can also be combined with telomere length assays to quantify positive regulation.
How EDITGENE Supports positive regulation of telomere maintenance via telomere lengthening Research
Researchers studying positive regulation of telomere maintenance via telomere lengthening-related genes often need to determine whether a candidate gene is causally involved in telomere elongation, whether a specific residue or modification is required, and whether gain-of-function is sufficient to drive the phenotype. Addressing these questions requires precise genome engineering and functional readouts that match the biology of GO:1904358 [2,6,7].
Contact EDITGENE today to design your custom CRISPR model for positive regulation of telomere maintenance via telomere lengthening research.
Frequently Asked Questions About positive regulation of telomere maintenance via telomere lengthening
What is GO:1904358?
GO:1904358 is the Gene Ontology biological_process term for positive regulation of telomere maintenance via telomere lengthening, defined as any process that activates or increases the frequency, rate or extent of telomere maintenance via telomere lengthening.
What does positive regulation of telomere maintenance via telomere lengthening mean?
It means any cellular activity that boosts telomere maintenance by making telomeres longer, including activation of telomerase-dependent or ALT-dependent elongation [2,4].
What genes are involved in positive regulation of telomere maintenance via telomere lengthening?
Genes experimentally linked to this process include TERT, POLD3, NPM1, HDAC9 and TERRA-associated factors such as Ess1 [2,6,7,8].
How is telomere lengthening regulated in ALT-positive cancers?
In ALT-positive osteosarcoma, NPM1 phosphorylation stabilizes POLD3 and promotes telomere maintenance via lengthening, while HDAC9 regulates ALT-associated PML bodies [2,6].
Why is GO:1904358 important in cancer research?
Positive regulators of telomere lengthening support replicative immortality, and TERT links telomere length to genomic instability and immune modulation in cancer [2,7].
What experimental models are used to study GO:1904358?
Common models include CRISPR knockout, point-mutation knock-in, knock-in of fusion alleles, and overexpression cell lines, combined with telomere length assays and imaging [2,5,6,7].
Which diseases are linked to positive regulation of telomere maintenance via telomere lengthening?
ALT-positive osteosarcoma, TERT-linked cancers, pancreatic neuroendocrine tumors and genome instability syndromes are relevant contexts [2,3,5,7].
How do you measure positive regulation of telomere lengthening?
Telomere length assays, RNA-seq for TERRA, phosphoproteomics for stabilization events, and imaging of ALT-associated PML bodies are standard readouts [2,6,8].
What is the difference between telomere maintenance and positive regulation of telomere maintenance via telomere lengthening?
Telomere maintenance is the core process, while GO:1904358 specifically annotates upstream activators that increase the frequency, rate or extent of lengthening.
Can CRISPR screens identify new regulators of telomere lengthening?
Yes, CRISPR library screening is used to identify genes required for telomere maintenance and to prioritize positive regulators for follow-up [2,6].
Conclusion
GO:1904358, positive regulation of telomere maintenance via telomere lengthening, provides a precise ontology anchor for genes that stimulate telomere elongation through telomerase-dependent or ALT-dependent routes [2,4]. Experimental work in ALT-positive osteosarcoma, TERT-driven cancers and related models has identified NPM1, POLD3, HDAC9 and TERRA-associated factors as key positive regulators [2,6,7,8]. Because these regulators are often therapeutically actionable, they are prime targets for CRISPR knockout, point-mutation, knock-in and overexpression studies [2,6,7]. Continued functional genomics of GO:1904358 will clarify how telomere lengthening is activated in disease and how it can be modulated [2,4,7].
References
- 1. Ganassi M et al.. 2022. Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies.. Eur J Transl Myol 32(1) PMID: 35302338
- 2. Zhao R et al.. 2026. NPM1 phosphorylation-mediated telomere maintenance via stabilization of POLD3 in ALT-positive osteosarcoma: unraveling mechanisms and therapeutic opportunities.. Theranostics 16(8):4224-4244 PMID: 41695477
- 3. Galati E et al.. 2021. VID22 counteracts G-quadruplex-induced genome instability.. Nucleic Acids Res 49(22):12785-12804 PMID: 34871443
- 4. Pompili L et al.. 2017. Diagnosis and treatment of ALT tumors: is Trabectedin a new therapeutic option?. J Exp Clin Cancer Res 36(1):189 PMID: 29273061
- 5. Wood-Trageser MA et al.. 2025. Recurrent BEND2 Fusion Genes Identified by Whole Transcriptome Sequencing of Nonfunctional Pancreatic Neuroendocrine Tumors Correlate With Poor Patient Prognosis.. Mod Pathol 38(10):100863 PMID: 40784487
- 6. Jamiruddin MR et al.. 2016. HDAC9 regulates the alternative lengthening of telomere (ALT) pathway via the formation of ALT-associated PML bodies.. Biochem Biophys Res Commun 481(1-2):25-30 PMID: 27833022
- 7. Zhao J et al.. 2025. TERT links telomere length to cancer risk by integrating genomic instability and immune modulation.. Discov Oncol 16(1):1788 PMID: 41026280
- 8. Chen J et al.. 2026. The Ess1 prolyl isomerase represses TERRA transcription and promotes telomere replication in Saccharomyces cerevisiae.. Genetics 232(3) PMID: 41557636
